IRS4 and cancer: Our results also imply that chronic β2-pS184 dephosphorylation in cancer cells (perhaps arising from sustained periods of low mTORC1 activity) contributes to survival and growth by providing a safeguard mechanism to preserve mTORC1 signalling through IRS4/Akt.